| Business Summary | | Tutogen
Medical,
Inc.
develops,
manufactures
and
markets
bio-implants
and
medical
devices
for
tissue
and
bone
repair
for
neuro,
orthopedic,
reconstructive
and
general
surgical
applications.
The
Company's
core
business
is
processing
human
donor
tissue
(allografts),
utilizing
its
proprietary
Tutoplast
process
of
tissue
preservation
and
viral
inactivation,
for
distribution
to
hospitals
and
surgeons.
One
of
the
Company's
wholly
owned
subsidiaries,
Tutogen
Medical
GmbH,
designs,
develops,
processes,
manufactures,
markets,
and
distributes
specialty
surgical
products
and
services
to
over
40
countries
through
a
worldwide
distribution
network.
Another
subsidiary,
Tutogen
Medical
(United
States),
Inc.,
was
formed
to
process,
market
and
distribute
allografts
for
the
United
States
market. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Tutogen
Medical
and
its
consolidated
subsidiaries
are
engaged
in
tissue
processing
and
distribution
of
specialty
surgical
products
for
neuro,
orthopedic,
reconstructive
and
general
surgical
applications.
For
the
nine
months
ended
6/30/01,
revenues
fell
25%
to
$9.8
million.
Net
income
before
accounting
change
fell
49%
to
$1.3
million.
Revenues
reflect
lower
surgical
product
sales
and
distribution
fees.
Earnings
also
reflect
higher
staff
and
marketing
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Thomas Pauken, 56 Chairman | -- | Manfred Kruger, 54 Pres,
Chief Operating and Exec. Officer | $266K | George Lombardi, 57 CFO,
Treasurer and Sec. | 182K | Dollar amounts are as of 30-Sep-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|